Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients

Figure 9

Freedom from allograft loss (a) and patient death (b) in DES (blue) versus non-DES (red) patients during the 1st 5 years after transplant. The group differences were assessed by the log-rank test.

(a) Graft loss (death-censored)

(b) Patient survival